Newborn Screening for Cystic Fibrosis, 2nd Edition

This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.

Members: $54.00 → $153.00

Nonmembers: $180.00
Log in/sign up to see price and add to cart


Chairholder: Debra Freedenberg, MD, PhD, FFACMG

Date of Publication: December 19, 2019

Order Code PDF: NBS05Ed2E
ISBN Number: 978-1-68440-065-2

Order Code Print: NBS05Ed2
ISBN Number: 978-1-68440-064-5

Edition: Second

Pages: 86

NBS05 Additional Details

A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.

This document was formerly sold under the code ILA35.